A Step towards Personalised Cancer Treatment in Lower Middle-income Countries (LMICS): Molecular Tumour Boards | [Journal of College of Physicians and Surgeons--Pakistan : JCPSP • 2023]

Author(s):

1. Agha Muhammad Hammad Khan: Department of Radiation Oncology, Sultan Qaboos Comprehensive Cancer Care and Research Centre,Muscat,Oman

2. Ikram Burney: Department of Medical Oncology, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman

3. Zeeshan Ansar: Department of Pathology, The Aga Khan University Hospital, Karachi, Pakistan

4. Ahmed Nadeem Abbasi: Department of Oncology, The Aga Khan University Hospital, Karachi, Pakistan

Abstract:

Tumour boards are meetings where physicians from various disciplines treating cancer patients meet to recommend evidence-based or the best possible treatment plan. These meetings have evolved with time and now, in every part of the world; site-speci c multi-disciplinary tumour boards are established. These meetings are considered pivotal for improving patient outcomes. The advances in molecular and genetic knowledge and technique and their integration in treatment options have paved the way for multiple therapeutic options. However, the adoption of personalised treatment choices is associated with a huge nancial burden, especially in low and middle-income countries (LMICs). A molecular tumour board can help to identify and suggest the most appropriate plan of management.

Page(s): 1070-1072

DOI: 10.29271/jcpsp.2023.09.1070

Published: Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 9, Year: 2023

Keywords:

Genetics , Challenges , Molecular , Personalised

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views